Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Sponsor: UCB Biopharma SRL
Summary
Phase 3 study to compare the efficacy of bimekizumab versus placebo in the treatment of subjects with moderate to severe chronic plaque psoriasis.
Official title: A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study With an Initial Treatment Period Followed by a Randomized-Withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
435
Start Date
2018-02-05
Completion Date
2020-01-07
Last Updated
2026-04-15
Healthy Volunteers
No
Interventions
Bimekizumab
Bimekizumab will be provided at pre-specified time intervals.
Placebo
Subjects will receive Placebo at pre-specified time points to maintain the blinding of the Investigational Medicinal Products.
Locations (77)
Ps0013 919
San Diego, California, United States
Ps0013 955
San Diego, California, United States
Ps0013 967
Santa Monica, California, United States
Ps0013 928
Fort Myers, Florida, United States
Ps0013 966
Sandy Springs, Georgia, United States
Ps0013 954
Skokie, Illinois, United States
Ps0013 962
Owensboro, Kentucky, United States
Ps0013 944
New Orleans, Louisiana, United States
Ps0013 940
Beverly, Massachusetts, United States
Ps0013 901
Portsmouth, New Hampshire, United States
Ps0013 956
Verona, New Jersey, United States
Ps0013 947
Buffalo, New York, United States
Ps0013 968
New York, New York, United States
Ps0013 965
New York, New York, United States
Ps0013 963
Rochester, New York, United States
Ps0013 949
Cleveland, Ohio, United States
Ps0013 929
Portland, Oregon, United States
Ps0013 937
Johnston, Rhode Island, United States
Ps0013 914
San Antonio, Texas, United States
Ps0013 933
Murray, Utah, United States
Ps0013 003
Carlton, Australia
Ps0013 008
East Melbourne, Australia
Ps0013 006
Kogarah, Australia
Ps0013 658
Ajax, Canada
Ps0013 672
Edmonton, Canada
Ps0013 671
Hamilton, Canada
Ps0013 675
Markham, Canada
Ps0013 663
Mississauga, Canada
Ps0013 660
Montreal, Canada
Ps0013 668
North Bay, Canada
Ps0013 667
Ottawa, Canada
Ps0013 665
Québec, Canada
Ps0013 676
Surrey, Canada
Ps0013 657
Waterloo, Canada
Ps0013 202
Hamburg, Germany
Ps0013 220
Hamburg, Germany
Ps0013 219
Münster, Germany
Ps0013 200
Schwerin, Germany
Ps0013 204
Witten, Germany
Ps0013 261
Budapest, Hungary
Ps0013 262
Miskolc, Hungary
Ps0013 253
Orosháza, Hungary
Ps0013 260
Szeged, Hungary
Ps0013 250
Szolnok, Hungary
Ps0013 258
Veszprém, Hungary
Ps0013 355
Bialystok, Poland
Ps0013 361
Bialystok, Poland
Ps0013 369
Bialystok, Poland
Ps0013 352
Gdansk, Poland
Ps0013 358
Katowice, Poland
Ps0013 359
Katowice, Poland
Ps0013 366
Katowice, Poland
Ps0013 357
Kielce, Poland
Ps0013 363
Krakow, Poland
Ps0013 360
Lodz, Poland
Ps0013 356
Lublin, Poland
Ps0013 374
Poznan, Poland
Ps0013 353
Szczecin, Poland
Ps0013 350
Warsaw, Poland
Ps0013 351
Warsaw, Poland
Ps0013 354
Warsaw, Poland
Ps0013 365
Wroclaw, Poland
Ps0013 368
Wroclaw, Poland
Ps0013 370
Wroclaw, Poland
Ps0013 400
Moscow, Russia
Ps0013 402
Moscow, Russia
Ps0013 403
Moscow, Russia
Ps0013 404
Saint Petersburg, Russia
Ps0013 405
Saint Petersburg, Russia
Ps0013 401
Saratov, Russia
Ps0013 406
Yaroslavl, Russia
Ps0013 701
Busan, South Korea
Ps0013 705
Seongnam-si, South Korea
Ps0013 703
Seoul, South Korea
Ps0013 550
Manchester, United Kingdom
Ps0013 554
Reading, United Kingdom
Ps0013 555
Salford, United Kingdom